Announcement • 4h
Tecsys Inc. to Report Q4, 2026 Results on Jun 29, 2026 Tecsys Inc. announced that they will report Q4, 2026 results After-Market on Jun 29, 2026 Announcement • 17h
Tecsys Achieves FedRAMP Agency Auth In Process Designation With HHS Sponsorship Tecsys Inc. has been officially designated as 'Agency Auth In Process' on the FedRAMP Marketplace, following sponsorship by the U.S. Department of Health and Human Services (HHS). The designation represents a key milestone in Tecsys’ progression toward FedRAMP Class C Certification (formerly Moderate). The Class C Certification covers systems handling sensitive data where unauthorized access, modification or loss would have serious consequences – a standard directly relevant in healthcare and mission-critical government operations. Through the HHS sponsorship, Tecsys is aligning its Elite platform with stringent federal security and compliance standards, enabling agencies to confidently deploy its advanced supply chain capabilities in highly regulated environments. Listing on the FedRAMP Marketplace as 'Agency Auth In Process' provides federal agencies with visibility into Tecsys’ progress toward certification and facilitates engagement with procurement and evaluation teams seeking compliant cloud solutions. With FedRAMP Class C Certification, Tecsys will further enable federal agencies to gain real-time visibility into critical medical and operational supply chains, strengthen resilience and continuity of operations, and meet stringent federal requirements for security, privacy, and compliance. Tecsys works with more than 1,000 customer sites worldwide across healthcare and distribution, including over 50 health systems such as Texas Children's Hospital, Intermountain Health and Sanford Health. Tecsys Elite, the company’s core platform, offers purpose-built capabilities with healthcare supply chain and warehouse management systems, pharmacy inventory management and hospital point-of-use visibility capabilities. Its Warehouse Management System was recently recognized by Gartner as a Challenger in the Magic Quadrant for the 15th consecutive year. New Risk • May 06
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: CA$158k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 8.6% per year over the past 5 years. Minor Risk Significant insider selling over the past 3 months (CA$158k sold). 
